Navigation Links
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Date:3/16/2009

  • Commercial Product Supply: In November, Poniard announced an agreement with Baxter Oncology GmbH for the commercial manufacture and supply of injectable picoplatin drug product. An agreement with W. C. Heraeus GmbH was established in March 2008 for the commercial manufacture of picoplatin active pharmaceutical ingredient.

  • Top 10 Oncology Product: In October, picoplatin was named by Windhover Information Inc., as one of the top 10 most promising oncology projects in development that is available for partnering.

Corporate Developments

  • Cash Position: The Company ended the year 2008 with cash and investment securities of $72.8 million. In September, Poniard drew down approximately $20 million of additional net cash proceeds under the Company's amended and restated loan facility with GE Healthcare Financial Services and Silicon Valley Bank.

  • New CFO: In February 2009, Greg Weaver was appointed Poniard's new chief financial officer and senior vice president. Mr. Weaver brings 17 years of experience in executive financial management to the Company, and has served as chief financial officer of public and private biotech and healthcare companies since 1996.

Fourth Quarter 2008 Financial Results

The Company reported a net loss of $13.9 million ($0.41 diluted loss per share on a loss applicable to common shares of $14.1 million) for the fourth quarter of 2008 compared with a net loss of $9.6 million ($0.28 diluted loss per share on a loss applicable to common shares of $9.7 million) for the fourth quarter of 2007. The Company reported a net loss of $48.6 million ($1.41 diluted loss per share on a loss applicable to common shares of
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Medical devices are any medical items that ... light of their different mechanisms, actions and regulatory requirements, ... than drug trails due to their unique clinical practices. ... evaluating both safety and efficacy (which is left to ... same as the SFDA) evaluate MDs for both safety ...
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   Shareholder rights ... of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities has filed ... District of Massachusetts .  The complaint ... the Securities Exchange Act of 1934 (the "Exchange Act") ... "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ) ...
(Date:5/17/2013)... , May 17, 2013  TechAtlas Group ... for their competitive landscape map for the Chronic ... over 90 international companies with drugs and devices ... CKD and its sequelae. (Logo:  ... , hypertension - renal denervation ...
Breaking Medicine Technology:Statistical Challenges in Medical Device Trail Evaluation 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2
... 2012  Regado Biosciences, Inc., a privately held company leading ... announced that David J. Mazzo, PhD, President and CEO, ... at 9:15 a.m. local time (3:15 a.m. EDT) on ... in Amsterdam, The Netherlands. The presentation will ...
... Fla., March 14, 2012  Nutra Pharma Corporation (OTCBB: NPHC), ... Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and ... an outside branding and marketing firm to aid in ... "We are excited to be working with ...
Cached Medicine Technology:Regado Biosciences, Inc. to Present at the BIO-Europe Spring® 2012 Conference in Amsterdam, The Netherlands 2Regado Biosciences, Inc. to Present at the BIO-Europe Spring® 2012 Conference in Amsterdam, The Netherlands 3Nutra Pharma Engages Marketing Firm for the Branding and Channel Development of Nyloxin™ 2Nutra Pharma Engages Marketing Firm for the Branding and Channel Development of Nyloxin™ 3
(Date:5/18/2013)... The Communities of Distinction TV ... call home. These are the townships, villages and other small ... where the people are friendly and neighbors are there when ... highways and shares the best in both the United States ... American sports and film celebrity. It airs in May and ...
(Date:5/18/2013)... May 18, 2013 Family Magazine of Washington ... excellence by Follow Media Consulting, Inc. in the category of ... continued commitment and dedication of the areas best in the ... one knows parenting better than Brenda Hyde, a mother of ... help parents know about the vast resources available to them ...
(Date:5/18/2013)... May 18, 2013 The “Sleep Apnea ... Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal ... to 2017” analyzes and studies the major market drivers, ... Rest of the World. , Browse , ... 16 Figures , 318 pagesand ...
(Date:5/18/2013)... The California College of Ayurveda Spa ... Ayurvedic Spa , the client receives stress relief ... and lifestyle recommendations and stress management techniques by a ... the traditional healthcare system of India. It is based ... the basis for all optimum health. Ayurveda believes that ...
(Date:5/18/2013)... Ohio (PRWEB) May 18, 2013 ... Annual Conference, on May 17-22 in Austin, TX ... gather for educational and networking opportunities. , ... brushes, flexible scope repair capabilities and ... with valuable educational information on proper instrument care ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2Health News:Spectrum Surgical Attends Society of Gastroenterology Nurses and Associates' (SGNA) 40th Annual Conference in Austin, TX 2
... new project is an interdisciplinary research project covering ... has been awarded EUR 6 million from the ... The project will gather scientists from seven countries, ... University of Gothenburg, Sweden. , Those working on ...
... more quickly and consistently WASHINGTON, May 26 As ... outbreak, many U.S. school and government leaders used notification ... updates and information - the latest example of the ... days when it might have taken officials days to ...
... helps explain association between the two illnesses , , TUESDAY, ... gum disease (periodontitis) and heart disease has been discovered ... coronary heart disease (CHD) has been known for years, ... confirmed. The University of Kiel team found that the ...
... in just four days, the mobile cloud computing solution shortens ... just two hoursSAN FRANCISCO, May 26 Salesforce.com (NYSE: ... that RehabCare Group, Inc. (NYSE: RHB ) has ... to run on its staff,s Apple iPhones. Built in ...
... immediate need to integrate our internal applications more robustly and ... testing, and deploying new interfaces within our timelines. , ... ... -- Seattle Radiologists APC, a regional, high volume, radiology group ...
... LONDON, May 26 The European prebiotics ... importance and value throughout the food and ... infant formula products, dairy and beverages and ... application sectors such as snack products and ...
Cached Medicine News:Health News:Sahlgrenska Academy to lead major European project on obesity 2Health News:Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform 2Health News:Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform 3Health News:Schools and Cities Send 9.7 Million Messages During Swine Flu Outbreak with Blackboard Connect(TM) Platform 4Health News:Gum Disease, Heart Disease Share Genetic Link 2Health News:RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone 2Health News:RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone 3Health News:RehabCare Leverages Force.com Platform to Build Custom Healthcare Application for use on Apple iPhone 4Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 2Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 3Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 4Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 2Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 3Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 4Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 5Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 6Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 7
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: